Janna Sisakyan/LinkedIn
Jul 30, 2025, 16:58
Janna Sisakyan: Myeloma 2024 Special Series
Janna Sisakyan, Assistant Managing Editor at OncoDaily, shared on LinkedIn:
“Call for Article Submissions: Myeloma 2024 Special Series
The OncoDaily Medical Journal is now inviting submissions for our upcoming ‘Myeloma 2024’ Special Series – a focused collection exploring new insights, breakthroughs, and challenges in the field of multiple myeloma.
Whether you’re working on basic science, clinical trials, real-world data, or expert perspectives, we welcome contributions that add value to the global oncology community.
Submission Deadline: August 30, 2024
More info and author guidelines.
Join us in spotlighting key developments in myeloma research and care.
Let’s publish science that matters.”
Other posts featuring Janna Sisakyan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 18, 2025, 17:21
Aug 18, 2025, 17:13
Aug 18, 2025, 17:04
Aug 18, 2025, 16:37
Aug 18, 2025, 16:33
Aug 18, 2025, 16:25
Aug 18, 2025, 16:10
Aug 18, 2025, 15:59